The short version of reference standard fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-07 and is reviewed periodically as new material appears.
Practical HPLC testing depends on careful sample preparation and instrument maintenance. Samples may require filtration, dilution, pH adjustment, or extraction to avoid column damage and matrix interference. Mobile phases are degassed and filtered, and columns are equilibrated before injection. Common problems include peak tailing, baseline drift, ghost peaks, carryover, and co-elution of analytes. Documentation of instrument logs, calibration records, and electronic audit trails supports data integrity and traceability. Ongoing training and routine maintenance help reduce variability between analysts and laboratories.
Quality control laboratories use HPLC to check identity, purity, concentration, and stability of raw materials and finished products. A validated method specifies the column, mobile phase, flow rate, detection wavelength, injection volume, and run time. Samples are prepared and compared against reference standards of known concentration. The resulting chromatogram provides quantitative data, such as assay values and impurity levels. This approach is common in pharmaceutical, food, environmental, and industrial testing where consistent measurements are required.
Method validation demonstrates that an analytical procedure is suitable for its intended purpose. Typical validation characteristics include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Regulatory guidance from bodies such as the International Council for Harmonisation and the United States Pharmacopeia outlines expectations, though specific criteria depend on the product and method. System suitability tests are run before sample analysis to confirm resolution, peak symmetry, column efficiency, and injection repeatability. Failure of these checks can invalidate a batch of measurements.
Routine quality control uses system suitability, blank injections, check standards, and control samples to detect drift or contamination. System suitability criteria may specify minimum resolution, maximum tailing factor, and a permitted range for repeated injections. Blank injections reveal carryover or solvent contamination, while check standards confirm calibration accuracy over a batch. Control samples with known analyte levels can show whether results remain within statistical limits. When a control result falls outside limits, the analyst investigates the cause and may invalidate affected results before repeating the batch.
Documentation and traceability are central to regulated HPLC testing. Records typically include instrument logs, column history, mobile-phase preparation, sample preparation, injection sequences, raw chromatograms, and audit trails. Electronic systems may require user access controls, time-stamped changes, and backup procedures. Training records show that analysts are qualified for assigned methods. Audits and inspections check whether written procedures match actual practice and whether deviations are documented. These controls support reproducibility and allow results to be reconstructed if questions arise later.
| Parameter | Typical acceptance criterion | Notes |
|---|---|---|
| Resolution | ≥ 1.5 | Baseline separation of adjacent peaks |
| Tailing factor | ≤ 2.0 | Peak symmetry measure |
| Theoretical plates | > 2000 | Column efficiency indicator |
| Injection repeatability | ≤ 2% RSD | Relative standard deviation for replicate injections |
| Linearity | r² ≥ 0.995 | Calibration curve over the working range |
Key performance measures include retention time, peak area, peak height, resolution, tailing factor, and plate count. Retention time helps identify a peak under fixed conditions, but confirmation often requires a second method or detector. Peak area and height relate to concentration through calibration curves, which may be linear or nonlinear depending on the detector response. Resolution describes separation between adjacent peaks, while tailing factor and plate count describe peak shape and column efficiency. Performance checks verify these values before and during a run to confirm that the instrument is performing within limits.
High-performance liquid chromatography testing separates components of a liquid sample by forcing a mobile phase through a packed column. The stationary phase inside the column interacts with analytes to different degrees, so each compound exits at a characteristic retention time. A pump delivers solvent at controlled flow and pressure, while an injector introduces a precise sample volume. Detectors such as ultraviolet-visible, fluorescence, refractive index, or mass spectrometric instruments record the separated bands. The resulting chromatogram provides qualitative and quantitative information about the mixture.
Routine quality control monitors retention time shifts, baseline noise, system pressure, and peak shape. Trends can reveal column aging, mobile phase preparation errors, detector drift, or sample degradation. Corrective actions may include replacing the column, preparing fresh mobile phase, or recalibrating the detector. Stability testing often uses HPLC to measure parent compound loss and degradation product formation. Open questions remain about how accelerated stability results extrapolate to long-term storage under varied conditions.
Quality control for HPLC testing combines scheduled checks, documented procedures, and review of results. Before sample analysis, system suitability testing confirms that the instrument, column, and method meet predefined criteria. Common criteria include resolution between critical peaks, retention time precision, peak tailing, and theoretical plate count. Failure triggers investigation before results are reported. Records link raw data, calculations, instrument logs, and analyst identity to each batch, supporting audits and repeat analysis.
=== Physical properties === Californium is a silvery-white actinide metal with a melting point of 900 ± 30 °C (1,650 ± 50 °F) and an estimated boiling point of 1,743 K (1,470 °C; 2,680 °F). The pure metal is malleable and is easily cut with a knife. Californium metal starts to vaporize above 300 °C (570 °F) when exposed to a vacuum. Below 51 K (−222 °C; −368 °F) californium metal is either ferromagnetic or ferrimagnetic (it acts like a magnet), between 48 and 66 K it is antiferromagnetic (an intermediate state), and above 160 K (−113 °C; −172 °F) it is paramagnetic (external magnetic fields can make it magnetic). It forms alloys with lanthanide metals but little is known about the resulting materials. The element has two crystalline forms at standard atmospheric pressure: a double-hexagonal close-packed form dubbed alpha (α) and a face-centered cubic form designated beta (β). The α form exists below 600–800 °C with a density of 15.10 g/cm3 and the β form exists above 600–800 °C with a density of 8.74 g/cm3. At 48 GPa of pressure the β form changes into an orthorhombic crystal system due to delocalization of the atom's 5f electrons, which frees them to bond. The bulk modulus of a material is a measure of its resistance to uniform pressure. Californium's bulk modulus is 50±5 GPa, which is similar to trivalent lanthanide metals but smaller than more familiar metals, such as aluminium (70 GPa).
== History == The first described attempts at producing weight loss are those of Soranus of Ephesus, a Greek physician, in the second century AD. He prescribed elixirs of laxatives and purgatives, as well as heat, massage, and exercise. This remained the mainstay of treatment for well over a thousand years. It was not until the 1920s and 1930s that new treatments began to appear. Based on its effectiveness for hypothyroidism, thyroid hormone became a popular treatment for obesity in euthyroid people. It had a modest effect but produced the symptoms of hyperthyroidism as a side effect, such as palpitations and difficulty sleeping. 2,4-Dinitrophenol (DNP) was introduced in 1933; this worked by uncoupling the biological process of oxidative phosphorylation in mitochondria, causing them to produce heat instead of ATP. Overdose caused fatal hyperthermia and DNP also caused cataracts in some users. After the passage of the Food, Drug, and Cosmetic Act in 1938, the FDA banned DNP for human consumption. Amphetamines (marketed as Benzedrine) became popular for weight loss during the late 1930s. They worked primarily by suppressing appetite, and had other beneficial effects such as increased alertness. Use of amphetamines increased over the subsequent decades, including Obetrol and culminating in the "rainbow diet pill" regime. This was a combination of multiple pills, all thought to help with weight loss, taken throughout the day.
== Plan Dignidad == In 1995 at the height of coca production, one out of every eight Bolivians made a living from coca. The country was the world's third largest grower of coca after Peru and Colombia. In 1997, 458 square kilometres of land were being used to produce coca leaves, with only 120 km2 of that being grown for the licit market. In August 1997, with strong support of the US government, Bolivian President Hugo Banzer developed "Plan Dignidad" ("The Dignity Plan") to counter the drug trade. The plan focused on eradication, interdiction (through lab destruction), efforts to counter money laundering, and implementation of social programs that countered and prevented drug addiction. The plan's heavy emphasis on plant eradication and noticeable lack of focus on trafficking organizations was noted by its critics at the time. The US Embassy in Bolivia defended the aggressive focus on crops, maintaining that Bolivia was devoid of significant trafficking organizations and claiming that the bulk of illegally exported coca went through small ‘mom-and-pop’ operations. This claim continues to be rejected by scholars of Bolivian society who say "Bolivia is very vulnerable to the influence of international trafficking organizations and that it is very likely that the participation of Bolivian entrepreneurs in the illegal business has increased." During the initial years of the operation area of coca production dropped. While in 1997 it had been 458 km2, by 1998 it was down to 380 km2; in 1999 it fell to 218 km2, and in 2000 it reached its lowest point at 146 km2.
For purposes of law enforcement, blood alcohol content is used to define intoxication and provides a rough measure of impairment. Although the degree of impairment may vary among individuals with the same blood alcohol content, it can be measured objectively and is therefore legally useful and difficult to contest in court. Most countries forbid operation of motor vehicles and heavy machinery above prescribed levels of blood alcohol content. Operation of boats and aircraft is also regulated. Some jurisdictions also regulate bicycling under the influence. The alcohol level at which a person is considered legally impaired to drive varies by country.
Sources: en.wikipedia.org
=== Misinformation === Naloxone has been subject to much inaccurate media reporting and many urban legends about it have become prevalent. One such myth is that naloxone makes the recipient violent. Another is that events called "Lazarus parties" have taken place, in which people reportedly took fatal overdoses in anticipation of being treated with naloxone; in reality this was a fiction spread by the police. Yet another is the claim that people have indulged in "yo-yoing", whereby they would take naloxone and opioids simultaneously to enjoy an extreme "high" and subsequent revival; the idea is scientifically nonsensical.
=== Legal status === The US Food and Drug Administration (FDA) approved trastuzumab deruxtecan in December 2019. The application for trastuzumab deruxtecan was granted accelerated approval, fast track designation, and breakthrough therapy designation. The FDA granted the approval of Enhertu to Daiichi Sankyo. In December 2020, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a conditional marketing authorization for the medicinal product Enhertu, intended for the treatment of metastatic HER2-positive breast cancer. Trastuzumab deruxtecan was reviewed under EMA's accelerated assessment program. The applicant for this medicinal product is Daiichi Sankyo Europe GmbH. Trastuzumab deruxtecan was approved for medical use in the European Union in January 2021. In January 2021, the FDA granted accelerated approval to trastuzumab deruxtecan for the treatment of adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen. In October 2021, the Australian Therapeutic Goods Administration approved trastuzumab deruxtecan for provisional registration indicated for the treatment of adults with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti HER2-based regimens.
==== Bone metabolism ==== In mice and humans, alterations in serotonin levels and signalling have been shown to regulate bone mass. Mice that lack brain serotonin have osteopenia, while mice that lack gut serotonin have high bone density. In humans, increased blood serotonin levels have been shown to be a significant negative predictor of low bone density. Serotonin can also be synthesized, albeit at very low levels, in the bone cells. It mediates its actions on bone cells using three different receptors. Through 5-HT1B receptors, it negatively regulates bone mass, while it does so positively through 5-HT2B receptors and 5-HT2C receptors. There is very delicate balance between physiological role of gut serotonin and its pathology. Increase in the extracellular content of serotonin results in a complex relay of signals in the osteoblasts culminating in FoxO1/ Creb and ATF4 dependent transcriptional events. Following the 2008 findings that gut serotonin regulates bone mass, the mechanistic investigations into what regulates serotonin synthesis from the gut in the regulation of bone mass have started. Piezo1 has been shown to sense RNA in the gut and relay this information through serotonin synthesis to the bone by acting as a sensor of single-stranded RNA (ssRNA) governing 5-HT production. Intestinal epithelium-specific deletion of mouse Piezo1 profoundly disturbed gut peristalsis, impeded experimental colitis, and suppressed serum 5-HT levels. Because of systemic 5-HT deficiency, conditional knockout of Piezo1 increased bone formation.
==== Gummy smiles ==== Up to 3mm of gingival display when smiling is described to be cosmetically acceptable. Gummy smiles are often used to describe smiles where there is more than 3mm of gingival tissue seen clinically and is usually deemed unaesthetic to the individual. Similar to subgingival crevices margins, gingivectomy to increase the crown height can be performed to provide better aesthetics and normal gingival architecture.
Its branching ratio relative to alpha decay is expected to increase with atomic number such that it may compete with alpha decay around Z = 120, and perhaps become the dominant decay mode for heavier nuclides around Z = 124. As such, it is expected to play a larger role beyond the center of the island of stability (though still influenced by shell effects), unless the center of the island lies at a higher atomic number than predicted.
Sources: en.wikipedia.org
Through individualized research projects, trainees gain practical experience in study design, experimental methods, data analysis, scientific communication, and responsible conduct of research while developing an appreciation for interdisciplinary approaches to aging science. In addition to mentored research, UT-MSTAR offers a structured educational curriculum that includes seminars on aging biology, geriatrics, research ethics, biostatistics, grant writing, scientific presentations, and career development. Students also participate in clinical shadowing experiences with geriatricians and clinician-scientists, allowing them to observe the translation of aging research into patient care and better understand the complex medical, functional, and psychosocial needs of older adults. At the conclusion of the program, trainees present their research at the annual UT-MSTAR consortium meeting and are encouraged to present their work at national scientific conferences. The long-term objective of UT-MSTAR is to strengthen the national pipeline of physician-scientists dedicated to aging research by fostering sustained interest in geriatrics, geroscience, and translational research. Through individualized mentorship, multidisciplinary training, clinical exposure, and collaboration across four UT medical schools, the program equips future physicians with the scientific foundation, research skills, and professional networks needed to pursue careers focused on improving the healthspan, independence, and quality of life of older adults.
Marsupial mulgaras have many resemblances to placental mice. Planigale has many resemblances to the deer mouse. The marsupial Tasmanian devil has many resemblances to the placental hyena or a wolverine. Similar skull morphology, large canines and crushing carnassial molars. Marsupial kangaroos and wallabies have many resemblances to the springhares, the viscachas (rodents which are also related to chinchillas), the maras (a large rodent from the cavy family (Caviidae)), and rabbits and hares (lagomorphs). The marsupial lion, Thylacoleo carnifex, had retractable claws, the same way the placental felines (cats) do today. Microbats, toothed whales and shrews developed sonar-like echolocation systems used for orientation, obstacle avoidance and for locating prey. Modern DNA phylogenies of bats have shown that the traditional suborder of echolocating bats (Microchiroptera) is not a true clade, and instead some echolocating bats are more related to non-echolocating Old World fruit bats than to other echolocating species. The implication is that echolocation in at least two lineages of bats, Megachiroptera and Microchiroptera has evolved independently or been lost in Old World fruit bats. Echolocation in bats and whales also both necessitate high frequency hearing. The protein prestin, which confers high hearing sensitivity in mammals, shows molecular convergence between the two main clades of echolocating bats, and also between bats and dolphins. Other hearing genes also show convergence between echolocating taxa.
== Synthesis == Phosphorimidazolide reagents have been synthesized from phosphate mono-esters. In one method, a phosphate mono-ester is dissolved in anhydrous pyridine or N,N-dimethylformamide (DMF) and activated using triphenylphosphine (PPh3) and 2,2’-Dithiodipyridine (2,2’-DTDP) in the presence of triethylamine (TEA) base and excess imidazole. In another method using fewer reagents, a phosphate mono-ester is dissolved in DMF and carbonyldiimidazole (CDI) is used to both remove an oxygen atom from the phosphate group and supply the imidazole substituent. The product of either reaction may be collected by precipitation using acetonitrile or acetone as antisolvent with sodium or lithium perchlorate to supply the sodium or lithium salt of the phosphorimidazolide respectively. Alternatively, the phosphorimidazolide may be isolated by reverse-phase flash column chromatography with TEAB buffer and acetonitrile.
This property has been utilized in synthetic organic chemistry. Selones (R2C=Se) are the selenium analogues of ketones. They are rare due to their tendency to oligomerize. Diselenobenzoquinone is stable as a metal complex. Selenourea is an example of a stable compound containing a (formal) C=Se bond. Thioselenides (R−Se−S−R), compounds with bonds between divalent selenium and divalent sulfur, analogous to disulfides. Likewise a selenamide has form R–Se–NR2. The latter are generally stable if and only if at least one of the nitrogen or the selenium is attached to an electron-withdrawing group. Per Paulmier, "hexacoordinated selenium does not appear in organic chemistry."
Fish protein powder (FPP) describes a food grade powder product designated primarily for human consumption applications. It differs significantly from fish meal products which are designated for animal feed applications. Fish protein powders have various sanitary processing, purity and functional characteristics which establish them as human food ingredients. Production plants registered for the USA market are located in Peru and France.
Sources: en.wikipedia.org
Method validation is the documented process of confirming that an HPLC procedure is suitable for its intended use. It evaluates accuracy, precision, specificity, linearity, range, detection limits, and robustness. Validation criteria depend on the regulatory context and the sample type.
System suitability tests are short checks performed before or during an HPLC run to verify instrument and method performance. They often include resolution, tailing factor, theoretical plates, and injection precision. Results must meet predefined limits for sample data to be accepted.
HPLC retention time alone cannot definitively identify an unknown substance. A match with a reference standard under identical conditions provides supporting evidence. Confirmation typically requires mass spectrometry, nuclear magnetic resonance, or another orthogonal technique.
Validation establishes suitability for a new method, while verification confirms that a method works in a specific laboratory. Verification is often used when a validated method is adopted with existing equipment and staff. Both rely on documented acceptance criteria.